MoonLake Immunotherapeutics
MLTX
$16.47
-$0.03-0.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.04% | -9.15% | 3.55% | -10.49% | -11.47% |
| Total Receivables | 13.85% | 18.36% | 21.06% | 17.98% | 14.09% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.75% | 44.19% | -14.44% | -1.02% | 16.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 43.72% | -5.94% | 2.55% | -9.72% | -10.03% |
|
|
|||||
| Total Current Assets | 43.72% | -5.94% | 2.55% | -9.72% | -10.03% |
| Net Property, Plant & Equipment | 7.37% | 11.48% | -15.40% | -13.19% | -11.58% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 125.50% | 1.53% | -65.41% | -0.06% |
| Total Assets | 43.35% | -5.67% | 2.44% | -9.95% | -10.01% |
|
|
|||||
| Total Accounts Payable | -27.13% | 6,305.48% | -44.10% | 8.47% | 4,200.00% |
| Total Accrued Expenses | 21.27% | -52.28% | -5.35% | 85.46% | 20.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.43% | -25.45% | -17.68% | -3.29% | 8.24% |
| Total Finance Division Other Current Liabilities | 68.17% | 27.51% | 7.89% | 21.29% | -62.54% |
| Total Other Current Liabilities | 68.17% | 27.51% | 7.89% | 21.29% | -62.54% |
| Total Current Liabilities | -1.57% | 1.40% | -5.98% | 76.78% | 14.09% |
|
|
|||||
| Total Current Liabilities | -1.57% | 1.40% | -5.98% | 76.78% | 14.09% |
| Long-Term Debt | 0.50% | 33.63% | 0.49% | 0.49% | 0.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.75% | 131.28% | -23.05% | -41.87% | -26.80% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -79.04% | -- | -- | -4.36% | 7.09% |
| Total Liabilities | -0.41% | 22.01% | -2.59% | 20.55% | 3.52% |
|
|
|||||
| Common Stock & APIC | 29.97% | 2.55% | 11.27% | 0.75% | 0.48% |
| Retained Earnings | -11.60% | -15.06% | -15.59% | -21.08% | -20.04% |
| Treasury Stock & Other | 95.65% | -46.69% | 117.27% | -46.54% | -78.22% |
| Total Common Equity | 68.56% | -16.57% | 5.39% | -18.33% | -13.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.56% | -16.57% | 5.39% | -18.33% | -13.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -45.76% | -16.76% |
| Total Equity | 68.56% | -16.57% | 4.56% | -18.65% | -13.24% |
|
|
|||||